How Has the Nasal Drug Delivery Technology Market Size Evolved in Recent Years?
The nasal drug delivery technology market has seen considerable growth due to a variety of factors.
•The market size for nasal drug delivery technology has seen a significant surge in recent times, with an anticipated growth from $80.79 billion in 2024 to $85.89 billion in 2025, marking a compound annual growth rate (CAGR) of 6.3%.
Factors like the evolution in drug formulation, a surge in respiratory disorders, patient inclination towards non-invasive delivery methods, a growing population of elderly people, and regulatory aids for nasal drug approvals have been pivotal to the growth during the historic period.
What are the Market Size and Expected Growth Rates for the Nasal Drug Delivery Technology Market?
The nasal drug delivery technology market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of nasal drug delivery technology is projected to witness significant growth in the coming years, with estimates forecasting a size of "$119.56 billion by 2029, reflecting a compound annual growth rate (CAGR) of 8.6%.
The expansion in the anticipated period is likely due to the growing prevalence of biologics and peptide therapies, emphasis on the needs of pediatric and geriatric patients, partnerships and collective efforts in the pharmaceutical industry, the broadening range of over-the-counter (OTC) nasal solutions, and an intensified focus on precision medicine. Key trends for the forecast period encompass advancements in formulation technologies, a heightened focus on user-friendly devices, widening of therapeutic areas, biologics and peptides delivery, and novelty in nasal spray technologies.
What Are The Essential Drivers Behind The Growth Of The Nasal Drug Delivery Technology Market?
The escalating numbers of chronic illnesses are anticipated to bolster the expansion of the nasal drug delivery technology market. Chronic diseases, which are conditions that persist for at least a year and necessitate continuous medical care, curtail daily activities, or both, make use of nasal drug delivery systems for the treatment of chronic rhinosinusitis. This technology enhances bacterial biofilm or mucociliary clearance brought about by the intricate structure of the nasal cavity via a therapeutic stratagem. For example, in August 2022, the American College of Cardiology—a non-profit medical organization based in the US—published a report stating that there will be a rising trend for all four major cardiovascular risk factors from 2025 to 2060 within the US. The report predicts that diabetes will experience the highest percentage surge, increasing by 39.3% to 55 million people. This will be followed by dyslipidemia, increasing by 27.6% to 126 million; hypertension, rising by 25.1% to 162 million; and obesity, bumping up by 18.3% to 126 million. Moreover, considerable growth in cardiovascular disease incidence is projected, with stroke rising by 33.8% to 15 million and heart failure by 33.4% to 13 million. Ischemic heart disease is forecasted to rise by 30.7% to 29 million and heart attack by 16.9% to 16 million. As such, the growing prevalence of chronic diseases is fueling the advancement of the nasal drug delivery systems market.
How Is The Global Nasal Drug Delivery Technology Market Divided Into Key Segments?
The nasal drug delivery technology market covered in this report is segmented –
1) By Dosage Form: Nasal Spray, Nasal Drops, Nasal Gels And Ointments, Nasal Powders, Other Dosage Forms
2) By Container Type: Pressurized Containers, Non-Pressurized Containers
3) By Therapeutic Application: Allergic And Non-Allergic Rhinitis, Nasal Congestion, Asthma, Vaccination, Other Therapeutic Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Home Care Settings, Hospitals
Subsegments:
1) By Nasal Spray: Metered-Dose Spray, Non-Metered-Dose Spray
2) By Nasal Drops: Liquid Nasal Drops, Gel-Based Nasal Drops
3) By Nasal Gels and Ointments: Hydrogel Formulations, Oil-Based Ointments
4) By Nasal Powders: Dry Powder Inhalers (DPI), Spray-Dried Powders
5) By Other Dosage Forms: Nasal Patches, Nasal Inserts
Pre-Book The Nasal Drug Delivery Technology Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Nasal Drug Delivery Technology Market?
One key trend emerging in the nasal drug delivery technology market is product innovation. Major players in this market are focusing on developing novel and superior products to offer fresh methods of drug delivery to consumers, thereby maintaining their market positions. An example of this was seen in January 2023 when AptarGroup, Inc., an American pharmaceutical and drug delivery firm, introduced the industry's first recyclable, metal-free, multidose nasal spray, known as APF Futurity. The spray, intended for delivering nasal saline and similar over-the-counter (OTC) formulations, is made from polyolefin materials, with no metal components or elements that could interrupt recycling. This design eliminates the need for separation during recycling, promoting a higher quality of recycled materials. The distinctive aspect of this product is its recyclability; it's a highly recyclable nasal spray pump that has achieved Class AA certification from cyclos-HTP for recycling streams in Europe.
Who Are the Key Players in the Nasal Drug Delivery Technology Market?
Major companies operating in the nasal drug delivery technology market include:
• AptarGroup Inc.
• Becton Dickinson and Company
• GlaxoSmithKline plc
• Johnson & Johnson Private Limited
• Novartis AG
• Pfizer Inc.
• 3M Company
• Cadila Healthcare Limited
• Neurelis Inc.
• OptiNose Inc.
• Bausch Health Companies Inc.
• Naveh Pharma Ltd.
• Teva Pharmaceutical Industries Ltd.
• Consort Medical plc
• Douglas Pharmaceuticals Ltd.
• ENT Technologies Pty. Ltd.
• Merck & Co. Inc.
• Sanofi SA
• AstraZeneca plc
• Boehringer Ingelheim International GmbH
• Bayer AG
• Abbott Laboratories
• Eli Lilly and Company
• Bristol-Myers Squibb Company
• Takeda Pharmaceutical Company Limited
• Amgen Inc.
• Gilead Sciences Inc.
• Biogen Inc.
• Roche Holding AG
• Allergan plc
• Regeneron Pharmaceuticals Inc.
• Alexion Pharmaceuticals Inc.
What are the Regional Insights into the Nasal Drug Delivery Technology Market?
North America was the largest region in the nasal drug delivery technology market in 2024. The regions covered in the nasal drug delivery technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
